Published in Health Business Week, February 16th, 2007
This is a critical step in the U.S. Food & Drug Administration approval process and comes after the successful conclusion of the feasibility phase of the trial.
The "focusAF" trial, the pivotal trial in the FDA approval process, will involve over 20 U.S. cardiac electrophysiology centers that specialize in the treatment of atrial fibrillation.
"The initiation of the pivotal study is a critical step along...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.